Document is current
Any future updates will be listed below
-
Authors
Gu, Stephanie
Menzer, Christian
Hay, Jennifer L.
Pena, Camila
Dusza, Stephen
Lacouture, Mario E.
Markova, Alina
- License Information
-
More Information
Article History
Received: 25 January 2023
Accepted: 1 May 2023
First Online: 15 May 2023
Declarations
:
: This is an observational study. The MSK Research Ethics Committee has confirmed that no ethical approval is required.
: No consent to publish is needed for this study.
: Informed consent was obtained from all individual patients included in this study.
: AM receives research funding from Incyte Corporation and Amryt Pharma; consults for ADC Therapeutics, Alira Health, Protagonist Therapeutics, OnQuality, and Janssen; and receives royalties from UpToDate. MEL has a consultant role with Johnson and Johnson, Novocure, Janssen, Novartis, Deciphera, Kintara, RBC/La Roche Posay, Trifecta, Genentech, Loxo, Seattle Genetics, Lutris, OnQuality, Roche, Oncoderm, Apricity. MEL also receives research funding from Lutris, Paxman, Novocure, OQL, Novartis and AZ, and is funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.
